Lawrence Biegelsen
Stock Analyst at Wells Fargo
(1.51)
# 3,456
Out of 4,944 analysts
53
Total ratings
57.58%
Success rate
-5.28%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lawrence Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDX Becton, Dickinson and Company | Maintains: Equal-Weight | $172 → $184 | $195.96 | -6.10% | 5 | Aug 8, 2025 | |
| PODD Insulet | Maintains: Overweight | $330 → $350 | $308.68 | +13.39% | 5 | Aug 8, 2025 | |
| ABT Abbott Laboratories | Maintains: Overweight | $147 → $142 | $129.40 | +9.74% | 6 | Jul 18, 2025 | |
| NPCE NeuroPace | Upgrades: Overweight | $16 → $20 | $9.32 | +114.59% | 7 | Mar 14, 2024 | |
| TNDM Tandem Diabetes Care | Maintains: Overweight | $166 → $82 | $11.13 | +636.75% | 5 | Aug 4, 2022 | |
| TFX Teleflex | Downgrades: Equal-Weight | $248 | $122.92 | +101.76% | 1 | Jul 29, 2022 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $350 → $339 | $482.35 | -29.72% | 2 | Apr 22, 2022 | |
| REE REE Automotive | Initiates: Underweight | $1.5 | $0.70 | +114.29% | 1 | Mar 25, 2022 | |
| LUNG Pulmonx | Maintains: Equal-Weight | $55 → $27 | $1.54 | +1,653.25% | 3 | Feb 24, 2022 | |
| ZBH Zimmer Biomet Holdings | Maintains: Underweight | $124 → $111 | $103.22 | +7.54% | 2 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $144 | $79.96 | +79.78% | 1 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $56 | $91.79 | -38.99% | 4 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $68 → $74 | $86.15 | -14.10% | 6 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $77 | $77.68 | -1.30% | 3 | Apr 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $85 → $90 | $11.62 | +674.53% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | n/a | $62.79 | - | 1 | Dec 12, 2019 |
Becton, Dickinson and Company
Aug 8, 2025
Maintains: Equal-Weight
Price Target: $172 → $184
Current: $195.96
Upside: -6.10%
Insulet
Aug 8, 2025
Maintains: Overweight
Price Target: $330 → $350
Current: $308.68
Upside: +13.39%
Abbott Laboratories
Jul 18, 2025
Maintains: Overweight
Price Target: $147 → $142
Current: $129.40
Upside: +9.74%
NeuroPace
Mar 14, 2024
Upgrades: Overweight
Price Target: $16 → $20
Current: $9.32
Upside: +114.59%
Tandem Diabetes Care
Aug 4, 2022
Maintains: Overweight
Price Target: $166 → $82
Current: $11.13
Upside: +636.75%
Teleflex
Jul 29, 2022
Downgrades: Equal-Weight
Price Target: $248
Current: $122.92
Upside: +101.76%
Intuitive Surgical
Apr 22, 2022
Maintains: Overweight
Price Target: $350 → $339
Current: $482.35
Upside: -29.72%
REE Automotive
Mar 25, 2022
Initiates: Underweight
Price Target: $1.5
Current: $0.70
Upside: +114.29%
Pulmonx
Feb 24, 2022
Maintains: Equal-Weight
Price Target: $55 → $27
Current: $1.54
Upside: +1,653.25%
Zimmer Biomet Holdings
Feb 8, 2022
Maintains: Underweight
Price Target: $124 → $111
Current: $103.22
Upside: +7.54%
Jan 19, 2022
Upgrades: Overweight
Price Target: $144
Current: $79.96
Upside: +79.78%
Jan 19, 2022
Upgrades: Equal-Weight
Price Target: $56
Current: $91.79
Upside: -38.99%
Oct 29, 2021
Maintains: Equal-Weight
Price Target: $68 → $74
Current: $86.15
Upside: -14.10%
Apr 28, 2020
Downgrades: Equal-Weight
Price Target: $77
Current: $77.68
Upside: -1.30%
Mar 5, 2020
Upgrades: Overweight
Price Target: $85 → $90
Current: $11.62
Upside: +674.53%
Dec 12, 2019
Upgrades: Overweight
Price Target: n/a
Current: $62.79
Upside: -